「바이오의약품 원료물질 및 원료의약품의 수입절차 특례 등에 관한 규정」 제정고시안 행정예고(식품의약품안전처 공고 제 2026-553호)

「바이오의약품 원료물질 및 원료의약품의 수입절차 특례 등에 관한 규정」 제정고시안 행정예고(식품의약품안전처 공고 제 2026-553호) | MFDS (South Korea) | RegulatoryAlerts

RegulatoryAlerts

Insights Blog Pricing Sign In Start Free Trial

Back to Home

MFDS (South Korea)

NOTICE

「바이오의약품 원료물질 및 원료의약품의 수입절차 특례 등에 관한 규정」 제정고시안 행정예고(식품의약품안전처 공고 제 2026-553호)

Published: 11/13/2026Detected: 11/13/2026

Summary preview

Announces for public comment a draft MFDS regulation establishing special import procedures for biological drug starting materials and active pharmaceutical ingredients (APIs).

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

#MFDS

#bioequivalence

#import procedures

#biological drug

#starting material

Official Source Document
Source Verified

Access the original document directly from MFDS.

View Official Document

Get MFDS (South Korea) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

Insights
Updates by Therapeutic Area
FDA Updates
EMA Updates
Pricing
Features
Request Demo

Resources

Integration Guides
Regulatory Glossary
EMA Timeline
Best Practices
Therapeutic Areas

Company

About Us
Blog
Contact

Security

Not affiliated with the FDA, EMA, or Health Canada.

Summary preview

Get the full analysis, free

Official Source Document Source Verified

More from MFDS (South Korea)

Get MFDS (South Korea) alerts in your inbox as they are published.

Official Source Document
Source Verified